These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31611329)

  • 1. Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.
    Mitchell AP; Kinlaw AC; Peacock-Hinton S; Dusetzina SB; Sanoff HK; Lund JL
    Oncologist; 2020 Jan; 25(1):46-54. PubMed ID: 31611329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments.
    Mitchell AP; Kinlaw AC; Peacock-Hinton S; Dusetzina SB; Winn AN; Sanoff HK; Lund JL
    Oncologist; 2024 Jun; 29(6):527-533. PubMed ID: 38484395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
    In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC
    Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What factors influence minority use of National Cancer Institute-designated cancer centers?
    Huang LC; Ma Y; Ngo JV; Rhoads KF
    Cancer; 2014 Feb; 120(3):399-407. PubMed ID: 24452674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
    Ho G; Wun T; Muffly L; Li Q; Brunson A; Rosenberg AS; Jonas BA; Keegan THM
    Cancer; 2018 May; 124(9):1938-1945. PubMed ID: 29451695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of care setting in the delivery of high-value colon cancer care.
    Veenstra CM; Epstein AJ; Liao K; Morris AM; Pollack CE; Armstrong KA
    Cancer; 2014 Oct; 120(20):3237-44. PubMed ID: 24954628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Payment methods for healthcare providers working in outpatient healthcare settings.
    Jia L; Meng Q; Scott A; Yuan B; Zhang L
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011865. PubMed ID: 33469932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
    Griffiths RI; Barron RL; Gleeson ML; Danese MD; O'Hagan A; Chia VM; Legg JC; Lyman GH
    Pharmacoeconomics; 2012 Feb; 30(2):103-18. PubMed ID: 21967155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Value for Pancreatic Surgery in Early-Stage Pancreatic Cancer.
    Bateni SB; Gingrich AA; Hoch JS; Canter RJ; Bold RJ
    JAMA Surg; 2019 Oct; 154(10):e193019. PubMed ID: 31433465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in patients, surgical complexity, and outcomes after cancer surgery at National Cancer Institute-designated cancer centers compared to other hospitals.
    Merkow RP; Bentrem DJ; Chung JW; Paruch JL; Ko CY; Bilimoria KY
    Med Care; 2013 Jul; 51(7):606-13. PubMed ID: 23604012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.
    Takvorian SU; Yasaitis L; Liu M; Lee DJ; Werner RM; Bekelman JE
    JAMA Netw Open; 2021 Aug; 4(8):e2119764. PubMed ID: 34342648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer.
    Roberts TJ; Kehl KL; Brooks GA; Sholl L; Wright AA; Landrum MB; Keating NL
    JAMA Netw Open; 2023 Apr; 6(4):e2310809. PubMed ID: 37115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H
    Ann Surg Oncol; 2024 Jul; 31(7):4339-4348. PubMed ID: 38506934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Maxillofacial Prosthetics for the Surgically Treated Patient at National Cancer Institute-Designated Comprehensive Cancer Centers.
    Rosen EB; Palin CL; Huryn JM; Wong RJ
    Laryngoscope; 2019 Feb; 129(2):409-414. PubMed ID: 30247745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minority Use of a National Cancer Institute-Designated Comprehensive Cancer Center and Non-specialty Hospitals in Two Florida Regions.
    Sultan DH; Gishe J; Hanciles A; Comins MM; Norris CM
    J Racial Ethn Health Disparities; 2015 Sep; 2(3):373-84. PubMed ID: 26863466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation Between Narrow Networks and Providers of Cancer Care.
    Yasaitis L; Bekelman JE; Polsky D
    J Clin Oncol; 2017 Sep; 35(27):3131-3135. PubMed ID: 28678667
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.